logo
logo

Quest Diagnostics Completes Acquisition Of Haystack Oncology, Adding Sensitive Mrd Liquid Biopsy Technology To Cancer Diagnostics Portfolio

Jun 21, 2023•about 2 years ago

Acquiring Company

Quest Diagnostics

Acquired Company

Haystack Oncology

SecaucusBaltimoreData And AnalyticsHealth CareBiotechnologyHealth CareMedical

Description

Quest Diagnostics (NYSE:DGX), the nation's leading provider of diagnostic information services, today announced that it has completed its previously announced acquisition of Haystack Oncology.

Company Information

Company

Quest Diagnostics

Location

500 Plaza Drive

Secaucus, New Jersey, United States

About

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com SOURCE Quest Diagnostics

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed